Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP)

Status Completed

Clinical Trial Summary

The investigators propose to study the safety of autologous mesenchymal stromal cell transfer using a biomatrix (the Gore Fistula Plug) in a Phase I study using a single dose of 20 million cells. 15 adult patients, ages 18 years and older with cryptoglandular fistulas will be enrolled. Subjects will undergo standard adjuvant therapy including drainage of infection and placement of a draining seton. Six weeks post placement of the draining seton, the seton will be replaced with the MSC loaded Gore Fistula Plug; fistula plug as per current clinical practice. The subjects will be subsequently followed for fistula response and closure for 24 months. This is an autologous product derived from the patient and used only for the same patient.

Clinical Trial Description

The investigators propose to study the safety of autologous mesenchymal stromal cell transfer using a biomatrix (the Gore® Bio-A® Fistula Plug) in a Phase I study using a single dose of 20 million cells. 15 adult patients (age > 18 years) with cryptoglandular fistulas will be enrolled. Subjects will undergo standard adjuvant therapy including drainage of infection and placement of a draining seton. Six weeks post placement of the draining seton, the seton will be replaced with the MSC loaded Gore® fistula plug as per current clinical practice. The subjects will be subsequently followed for fistula response and closure for 24 months. Study visits are Day 1, Week 2, Week 4, Week 8, Week 12, Week 24, Week 52, and Week 104. This is an autologous product derived from the patient and used only for the same patient. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02589119
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	Phase 1
Start date	January 2016
Completion date	September 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03913572` - Treatment of Perianal Disease Using Adipose-derived Stem Cells
Terminated	`NCT01623453` - Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211)	N/A
Completed	`NCT06441526` - Surgical Closure vs Anti-TNF in the Treatment of Perianal Fistulas in Crohn's Disease (PISA-II): a Comprehensive Cohort Design	Phase 3
Recruiting	`NCT04847739` - Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)	Phase 2
Completed	`NCT06314945` - Diagnostic Value of Recto-perineal Ultrasound in Perianal Fistula
Completed	`NCT03763981` - Comparison of Prolene Thread Seton Vs Silk Thread Seton for the Treatment of Perianal Fistula	N/A
Not yet recruiting	`NCT05626023` - A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease	Phase 1/Phase 2
Completed	`NCT01021774` - Anal Fistula Treatment Outcome - Collagen Plug Versus Advancement Flap Surgery	N/A
Recruiting	`NCT04519671` - Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease	Phase 1/Phase 2
Active, not recruiting	`NCT04549311` - Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial	Phase 3
Completed	`NCT03555773` - Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas	N/A
Recruiting	`NCT03707769` - TIPS Microspheres for Perianal Fistula	N/A
Completed	`NCT03803917` - Adipose Tissue in Crohn´s Disease Fistulas	N/A
Recruiting	`NCT03322488` - Fistulodesis Pilot Study for Closure of Perianal Fistulae	N/A
Withdrawn	`NCT03014219` - Phase 1 Crohn's Pediatric Sub-study of MSC AFP	Phase 1
Completed	`NCT03209700` - Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas	Phase 1
Completed	`NCT03981939` - Perianal Fistula (PAF) Validation and Burden of Illness Study
Recruiting	`NCT05721794` - Comparative Accuracy of Transperineal Ultrasound (TPUS) Versus Magnetic Resonance Imaging (MRI) for the Assessment of Perianal Fistulae in Patients With Crohn's Disease (CD): a Prospective Observational Longitudinal Cohort Study
Enrolling by invitation	`NCT03861689` - Tight Control Management in Perianal Crohn's Disease	N/A
Not yet recruiting	`NCT05709717` - Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases